Håll dig uppdaterad med våra pressmeddelanden
The board of directors of ChromoGenics has resolved on record date for the reverse share split
At the annual general meeting in ChromoGenics AB (publ) (“ChromoGenics” or the ”Company”) on 21 June 2023 it was resolved on a reverse share split, through which one hundred existing shares will be consolidated into one share (Sw. Sammanläggning 1:100). The board of directors was authorized by the annual general meeting to resolve on the record date for the reverse share split. The board of directors has now resolved that the record date for the reverse share split will be 12 September 2023.
The board of directors’ resolution means that the last day of trading in ChromoGenics’ share prior to the reverse share split will be 8 September 2023 and the first day of trading in the share after the reverse share split will be 11 September 2023. This means that the share price as from and including 11 September 2023 will reflect the effect of the reverse share split. As a result of the reverse share split, the shares in ChromoGenics will as from and including 11 September 2023 have a new ISIN-code: SE0020847481.
Following the reverse share split, the number of shares in the Company will decrease from 411,898,778 to 4,118,987.
For more information, please contact:
Fredrik Fränding, CEO
Tel: +46(0)72 249 24 62
The information was submitted for publication, through the agency of the contact persons set out above, at 17:45 CEST on 4 September 2023.
ChromoGenics is a PropTech company that produces dynamic glass for real estate. One company product, ConverLight® Dynamic, controls indoor comfort by optimising daylighting, good views and blocking solar heat, and thereby contributing to reducing costs for cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are sputtered onto plastic film and then laminated between glass layers. The plastic film is easy to transport which means long distance shipping of bulky glass can be avoided. ChromoGenics also offers ConverLight® Static, a static glass version, and a façade glazing solution, ConverLight® Energy. ChromoGenics has supplied glazing technology to a large number of major real estate companies. Its shares were listed on the Nasdaq First North Growth Market in 2017.
ChromoGenics emerged from world-leading research at the Ångström Laboratory at Uppsala University. The company’s production site in Uppsala has been partly financed via conditional loans from the Swedish Energy Agency. ChromoGenics shares (CHRO) are listed on the Nasdaq First North Growth Market with Vator Securities AB as Certified Adviser: firstname.lastname@example.org, +46(0)8-580 065 99.
Med delfinansiering från